Selected Publications

Goldman JL, Chung WH, Lee BR, Chen CB, Lu CW, Hoetzenecker W, Micheletti R, Yasuda SU, Margolis DJ, Shear NH, Struewing JO, Primohamed M: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. Eur J Clin Pharmacol 75(9): 1331, Sept 2019.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen D, Gottlieb A, Hamzavi I, Hazen P, Jaleel T, Kimball A, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y: North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: Topical, Intralesional, and Systemic medical Management. J Am Acad Dermatol 81(1): 91-101, Jul 2019.

Micheletti RG: The potential cost-savings of tumour necrosis factor inhibitors for hidradenitis suppurativa. Br J Dermatol 180(5): 988-89, May 2019.

Noe MH, Micheletti RG, Mostaghimi A: Society of Dermatology Hospitalists SJS/TEN Study Group. Timing of Mucocutaneous Symptoms and Medication Discontinuation in Patients with SJS/TEN in the United States. J Am Acad Dermatol 19: 30783-2, May 2019.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen D, Gottlieb A, Hamzavi I, Hazen P, Jaleel T, Kimball A, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y: North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complimentary and Procedural Management. J Am Acad Dermatol 81(1): 76-90, Mar 2019.

Noe MH, Rosenbach M, Hubbard RA, Cardones A, Chen J, Cotliar J, Davis M, Dominguez A, Fox L, Kaffenberger B, Kroshinsky D, Kwong B, Miller D, Mostaghimi A, Musiek A, Ortega-Loayza A, Sharon V, Shinkai K, Summers E, Sun N, Wanat K, Wetter D, Worswick S, Margolis D, Gelfand J, Micheletti RG: ABCD-10: A Novel Mortality Prediction Tool for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Derived from a Multicenter Cohort in the United States. JAMA Dermatol Mar 2019.

Shavit E, Alavi A, Bechara FG, Bennett RG, Bourcier M, Cibotti R, Daveluy S, Frew JW, Garg A, Hamzavi I, Hoffman LK, Hsaio J, Kirby JS, Lev-Tov H, Martinez E, Micheletti R, Naik HB, Nassif A, Nicholson C, Parks-Miller A, Patel Z, Piguet V, Ramesh M, Resnik B, Sayed C, Schultz G, Siddiqui A, Tan J, Wortsman X, Lowes MA: Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017. Exp Dermatol 28(1): 94-103, Jan 2019.

Micheletti RG, Chiesa-Fuxench Z, Noe M, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones A, Chen J, Cotliar J, Davis M, Dominguez A, Fox L, Gordon S, Hamrick R, Ho B, Hughey L, Jones L, Kaffenberger B, Kindley K, Kroshinsky D, Kwong B, Miller D, Mostaghimi A, Musiek A, Ortega-Loayza A, Patel R, Posligua A, Rani M, Saluja S, Sharon V, Shinkai K, St. John J, Strickland N, Summers E, Sun N, Wanat K, Wetter D, Worswick S, Yang C, Margolis D, Gelfand J, Rosenbach M: Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis: a multicenter retrospective study of 377 adult patients from the United States. J Invest Dermatol 138(11): 2315-21, Nov 2018 Notes: Epub ahead of print.

Micheletti RG: Cutaneous vasculitis in rheumatologic disease: Current concepts of skin and systemic manifestations. Clin Dermatol 36(4): 561-66, Jul - Aug 2018.

Jayakumar KL, Samimi SS, Vittorio CC, Micheletti RG, Steele KT, Ogunleye TA, Richardson V, Chiesa ZC, Rosenbach M: Expediting patient appointments with dermatology rapid access clinics. Dermatol Online J. 24(6), Jun 2018.